Motohiro Yukitake Selected Research

Hemostatics (Antihemorrhagics)

1/2013

[A case of superficial siderosis treated with intravenous and oral hemostatic drugs].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Motohiro Yukitake Research Topics

Disease

4	Multiple Sclerosis 05/2019 - 08/2003
3	Tropical Spastic Paraparesis (Tropical Spastic Paraplegia) 04/2008 - 08/2003
2	Inflammation (Inflammations) 05/2022 - 08/2003
2	Cognitive Dysfunction 01/2022 - 01/2013
1	Coinfection 05/2022
1	Immune Reconstitution Inflammatory Syndrome 05/2022
1	Meningeal Tuberculosis (Tuberculous Meningitis) 05/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Erythema 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hypokinesia (Bradykinesia) 01/2022
1	Mycosis Fungoides 01/2022
1	Ovarian Teratoma 01/2014
1	Teratoma (Teratoid Tumor) 01/2014
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2014
1	Encephalitis (Encephalitis, Rasmussen) 01/2014
1	Unconsciousness (Loss of Consciousness) 10/2013
1	Neurologic Manifestations (Neurological Manifestations) 10/2013
1	Stroke (Strokes) 10/2013
1	Ischemic Stroke 10/2013
1	Cryptogenic Organizing Pneumonia 01/2013
1	Lymphoma (Lymphomas) 01/2013
1	Siderosis 01/2013
1	Progressive Multifocal Leukoencephalopathy 01/2013
1	Spinal Cord Diseases 04/2008
1	Atrophy 01/2008
1	Myasthenia Gravis 01/2008
1	Paraparesis 01/2008
1	Macrocytic Anemia 04/2007
1	Paraplegia (Spastic Paraplegia) 01/2006
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 02/2005
1	Torticollis (Wryneck) 01/2004
1	Polyradiculoneuropathy (Polyradiculoneuritis) 01/2004
1	Cerebellar Ataxia (Dysmetria) 12/2003
1	Myelitis 08/2003
1	Meningoencephalitis 08/2003
1	Leukocytosis (Pleocytosis) 08/2003
1	Cerebral Infarction 08/2003

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2014 - 12/2004
2	SteroidsIBA 01/2022 - 01/2008
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 04/2008 - 12/2004
2	Immunoglobulin G (IgG)IBA 01/2008 - 08/2003
2	Proteins (Proteins, Gene)FDA Link 12/2004 - 08/2003
1	Pharmaceutical PreparationsIBA 05/2022
1	Brentuximab VedotinIBA 01/2022
1	Ficusin (Psoralen)IBA 01/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2013
1	Mefloquine (Lariam)FDA LinkGeneric 01/2013
1	Hemostatics (Antihemorrhagics)IBA 01/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2008
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 04/2007
1	SpastinIBA 01/2006
1	SS-A antibodiesIBA 02/2005
1	AutoantigensIBA 12/2004
1	Type A Botulinum Toxins (Botox)FDA Link 01/2004
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2004
1	Messenger RNA (mRNA)IBA 12/2003
1	PrionsIBA 08/2003
1	Phosphopyruvate Hydratase (Enolase)IBA 08/2003
1	14-3-3 Proteins (14-3-3 Protein)IBA 08/2003

Therapy/Procedure

6	Therapeutics 05/2022 - 01/2004
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2013
1	Hematopoietic Stem Cell Transplantation 01/2022
1	PUVA Therapy 01/2022
1	Activities of Daily Living (ADL) 01/2008
1	Injections 01/2004